{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:42:23Z","timestamp":1788306143443,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100014269","name":"Uniwersytet Medyczny w Bia\u0142ymstoku","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.advms.2020.11.004","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T18:00:43Z","timestamp":1606845643000},"page":"35-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lack of change in serum sCD36 concentration in children with non-alcoholic fatty liver disease \u2013 A preliminary study"],"prefix":"10.1016","volume":"66","author":[{"given":"Anna","family":"Bobrus-Chociej","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Wasilewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Harasim-Symbor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Flisiak-Jackiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Wojtkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Chabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Lebensztejn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.advms.2020.11.004_bib1","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/ajg.2010.152","article-title":"Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease","volume":"105","author":"Patton","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.advms.2020.11.004_bib2","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/gut.2008.171280","article-title":"The natural history of non- alcoholic fatty liver disease in children: a follow- up study for up to 20 years","volume":"58","author":"Feldstein","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.advms.2020.11.004_bib3","first-page":"54","article-title":"The spectrum of fatty liver in obese children and the relationship of serum aminotransferases to severity of steatosis","volume":"36","author":"Fishbein","year":"2003","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.advms.2020.11.004_bib4","first-page":"319","volume":"64","author":"Vos","year":"2017","journal-title":"JPGN"},{"key":"10.1016\/j.advms.2020.11.004_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms17060947","article-title":"A\u00a0guide to non- alcoholic fatty liver disease in childhood and adolescence","volume":"17","author":"Temple","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.advms.2020.11.004_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1017\/S0029665110000030","article-title":"Non-alcoholic fatty liver disease: the hepatic consequences of obesity and the metabolic syndrome","volume":"69","author":"Moore","year":"2010","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.advms.2020.11.004_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/eci.12192","article-title":"Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease","volume":"44","author":"Garcia-Monzon","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.advms.2020.11.004_bib8","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1152\/ajpgi.00074.2008","article-title":"Gene expression in human NAFLD","volume":"294","author":"Greco","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.advms.2020.11.004_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1152\/physiologyonline.2007.22.1.15","article-title":"Is membrane transport of FFA mediated by lipid, protein or both? Mechanisms and regulation of protein- mediated cellular fatty acid uptake: molecular, biochemical and physiological evidence","volume":"22","author":"Bonen","year":"2007","journal-title":"Physiology"},{"key":"10.1016\/j.advms.2020.11.004_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/13813455.2010.543136","article-title":"Soluble CD36- a marker of the (pathophysiological) role of CD36 in the metabolic syndrome?","volume":"117","author":"Koonen","year":"2011","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.advms.2020.11.004_bib11","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"HOMA-IR and beta-cell function from fasting plasma glucose and insulin concentration in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.advms.2020.11.004_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.292.6512.13","article-title":"Ultrasound scanning in the detection of hepatic fibrosis and steatosis","volume":"292","author":"Saverymuttu","year":"1986","journal-title":"Br Med J"},{"key":"10.1016\/j.advms.2020.11.004_bib13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1203\/PDR.0b013e318165b8e7","article-title":"Nonalcoholic fatty liver disease and carotid atherosclerosis in children","volume":"63","author":"Pacifico","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1016\/j.advms.2020.11.004_bib14","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1210\/jc.2009-2002","article-title":"Soluble CD36 (sCD36) clusters with markers of insulin resistance and high sCD36 is associated with increased type 2 diabetes risk","volume":"95","author":"Handberg","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.advms.2020.11.004_bib15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2796.2011.02442.x","article-title":"Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population","volume":"271","author":"Handberg","year":"2012","journal-title":"J\u00a0Intern Med"},{"issue":"2","key":"10.1016\/j.advms.2020.11.004_bib16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ijo.2016.223","article-title":"Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls","volume":"41","author":"Heeb\u00f8ll","year":"2017","journal-title":"Int J Obes"},{"issue":"72","key":"10.1016\/j.advms.2020.11.004_bib17","first-page":"2","article-title":"CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior","volume":"26","author":"Silverstein","year":"2009","journal-title":"Sci Signal"},{"key":"10.1016\/j.advms.2020.11.004_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.18632\/aging.100652","article-title":"Increased hepatic CD36 expression with age is associated with enhanced susceptibility to nonalcoholic fatty liver disease","volume":"6","author":"Sheedfar","year":"2014","journal-title":"Aging"},{"issue":"5","key":"10.1016\/j.advms.2020.11.004_bib19","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3892\/br.2016.622","article-title":"Soluble cluster of differentiation 36 concentrations are not associated with cardiovascular risk factors in middle-aged subjects","volume":"4","author":"Alkhatatbeh","year":"2016","journal-title":"Biomed Rep"},{"issue":"4","key":"10.1016\/j.advms.2020.11.004_bib20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1538-7836.2011.04220.x","article-title":"The putative diabetic plasma marker, soluble CD36, is non-cleaved, non-soluble and entirely associated with microparticles","volume":"9","author":"Alkhatatbeh","year":"2011","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"9","key":"10.1016\/j.advms.2020.11.004_bib21","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/ejcn.2016.88","article-title":"Reduced sCD36 following weight loss corresponds to improved insulin sensitivity, dyslipidemia and liver fat in obese children","volume":"70","author":"Kn\u00f8sgaard","year":"2016","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"10.1016\/j.advms.2020.11.004_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.arcped.2018.01.008","article-title":"CD36 gene polymorphism and plasma sCD36 as the risk factor in higher cholesterolemia","volume":"25","author":"Ra\u0107","year":"2018","journal-title":"Arch Pediatr"},{"issue":"1","key":"10.1016\/j.advms.2020.11.004_bib23","first-page":"15","article-title":"Nonalcoholic fatty liver disease: a challenge from mechanisms to therapy","volume":"9","author":"Tarantino","year":"2020","journal-title":"J\u00a0Clin Med"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112620300444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112620300444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:40:26Z","timestamp":1761824426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112620300444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1896112620300444"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2020.11.004","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lack of change in serum sCD36 concentration in children with non-alcoholic fatty liver disease \u2013 A preliminary study","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2020.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}